In a randomized controlled trial, Laurenzi et al. [27] concluded that patients with T1DM using continuous subcutaneous insulin infusion with carbohydrate counting showed reduced HbA1c levels. The gene discussed is INS; the disease is type 1 diabetes mellitus.